Merck ready to deliver 10 million doses of its Covid antiviral pill by the end ...

Merck ready to deliver 10 million doses of its Covid antiviral pill by the end ...
Merck ready to deliver 10 million doses of its Covid antiviral pill by the end ...
Merck CEO says the firm is ready to deliver 10 million doses of its Covid antiviral pill by the end of the year if it receives FDA approval Robert Davis, CEO of Merck, says the company is prepped to ship out ten million doses of molnupiravir, the company's new Covid pill by the end of the year The drug, which is gaining momentum around the world, showed it could slash Covid hospitalizations and deaths in half Merck is seeking FDA emergency use authorization in the United States, along with regulatory approval in many nations worldwide Unlike other Covid treatment, the administration of molnupiravir can be done without using too many resources  like special equipment or staff to monitor

View
comments

Pharmaceutical company Merck & Co is set to distribute millions of doses of its new Covid pill by the end of the year if it receives approval from federal regulators.

Robert Davis, CEO of the Kenilworth, New Jersey-based company, told CNBC on Thursday that the firm is ready to deploy massive shipments of the drug as soon as it gets the greenlight from the U.S. Food and Drug Administration (FDA). 

The pill, molnupiravir, has been found to slash the rate of hospitalization and death in half if taken in the days immediately following infection.

It is the first oral medication with the ability to fight the virus, and has been dubbed a 'game changer' by some experts due to its effectiveness and the ease of administering it. 

Merck CEO Robert Davis (left) told CNBC on Thursday that his company is prepared to distribute 10 million doses of their new Covid pill, molnupiravir, by the end of the year if it gets federal approval

Merck CEO Robert Davis (left) told CNBC on Thursday that his company is prepared to distribute 10 million doses of their new Covid pill, molnupiravir, by the end of the year if it gets federal approval

Molnupiravir (pictured) is the first oral medication that can combat COVID-19. While the vaccine is always preferred, many are hopeful the drug could help fight the virus in lower income nations where the vaccine is not readily available

Molnupiravir (pictured) is the first oral medication that can combat COVID-19. While the vaccine is always preferred, many are hopeful the

read more from dailymail.....

PREV Dietitians reveal why protein powders, shakes and gels are a waste of money ... trends now
NEXT No wonder you can't get an NHS dentist appointment! Outrage as taxpayer-funded ... trends now